Brain-Based Biomarkers in Response to TMS in MDD

Trial ID or NCT#

NCT02843373

Status

not recruiting iconNOT RECRUITING

Purpose

The overarching goal of this research program is to elucidate causal and directional neural network- level abnormalities in depression, and how they are modulated by an individually-tailored, circuit-directed intervention. By using concurrent TMS and EEG, the investigators can overcome a major limitation of EEG - the inability to demonstrate causality. Here, we plan to recruit patients with medication-resistant depression undergoing rTMS treatment. At multiple time points, we will perform TMS-EEG to investigate the excitability and connectivity profiles of brain networks and how they are modulated during treatment. This study aims to provide objective brain network measures that can predict and track clinical response to TMS treatment. Findings from this study will be utilized to develop a novel, personalized treatment protocol based on individual brain networks.

Official Title

Longitudinal, Prospective Study to Examine the Brain-based Biomarkers of Response to Transcranial Magnetic Stimulation Treatment in Major Depressive Disorder

Eligibility Criteria

Ages Eligible for Study: 18 Years to 60 Years
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: No
Inclusion Criteria:
  1. * Men and women, ages 18 to 60* Medication-resistant depression as assessed by psychiatrist* Must comprehend English well to ensure adequate comprehension of the EEG and TMS instructions, and of clinical scales* Has failed \>1 previous adequate antidepressant medication trials* Right-handed* No current or history of neurological disorders* No seizure disorder or risk of seizures* No use of PRN medication within 48 hours of the scheduled study appointment
Exclusion Criteria:
  1. * Any unstable medical condition, any significant CNS neurological condition such as stroke, seizure, tumor, hemorrhage, multiple sclerosis, etc* Current electroconvulsive therapy (ECT) or prior treatment failure with ECT* Currently pregnant or breastfeeding

Investigator(s)

Corey Keller, MD, PhD

Contact us to find out if this trial is right for you.

Contact

Corey Keller, MD PhD